Jiangsu Recbio Technology Co., Ltd. Class H (HK:2179) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Jiangsu Recbio Technology Co., Ltd. plans to issue up to 143 million domestic shares, aiming to bolster its competitiveness and fund research and development initiatives. The shares will be offered to Yangtze River Pharmaceutical at RMB5.59 each, pending approval at an extraordinary general meeting. Investors are advised to remain cautious as the issuance is subject to certain conditions.
For further insights into HK:2179 stock, check out TipRanks’ Stock Analysis page.